FDA speeding up clinical trials
The Brown University Child & Adolescent Psychopharmacology Update · 2026-07 · 28 (7) · 7-8
DOI: 10.1002/cpu.31076 ↗At a glance
Journal article in The Brown University Child & Adolescent Psychopharmacology Update, published online on 2026-07-13.
Abstract (original language)
The U.S. Food and Drug Administration (FDA) is announcing actions to accelerate and modernize clinical research across the full continuum of drug development — from the Investigational New Drug (IND) phase to late‐stage pivotal trials. The FDA's work is outlined in Operation TrialBlazer , a U.S. Department of Health and Human Services (HHS) initiative.
Cite
APA
(2026). FDA speeding up clinical trials. The Brown University Child & Adolescent Psychopharmacology Update, 28(7), 7-8. https://doi.org/10.1002/cpu.31076
Vancouver
FDA speeding up clinical trials. The Brown University Child & Adolescent Psychopharmacology Update. 2026;28(7):7-8. doi:10.1002/cpu.31076
BibTeX
@article{euvimed2026,
title = {FDA speeding up clinical trials},
journal = {The Brown University Child & Adolescent Psychopharmacology Update},
year = {2026},
volume = {28},
number = {7},
pages = {7--8},
doi = {10.1002/cpu.31076}
}
EUVIMED